NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN Clinical Practice Guidelines in Oncology(TM) for Breast Cancer to determine an individualized treatment regimen. The program, which provides free CME credits, premieres on Sunday, November 22 at 7:00 am EST.
Although October (National Breast Cancer Awareness Month) is behind us, it remains imperative for both physicians and patients to keep up-to-date on the latest treatment developments for breast cancer, as well as all types of cancer. Metastatic breast cancer is breast cancer that has spread beyond the breast into places such as the bones, lungs, liver, or brain. Although metastatic breast cancer is not curable, there are many effective treatments, including a number of recent treatment advances that are enabling women with metastatic breast cancer to live longer and better lives. However, treatment needs to be highly individualized as no single treatment plan is right for everyone.
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, has collaborated with the Discovery Health Channel to produce a program profiling three patients with metastatic breast cancer and their healthcare team as they customize each patient's treatment regimen to their individual tumor type and health status. The program, Metastatic Breast Cancer: Individualizing Treatment, premieres Sunday, November 22, 2009 at 7 am EST on the Discovery Health Channel. This program is available for Continuing Medical Education (CME/CE) credits for physicians as well as nurses.
"Discovery Health is thrilled to continue its ongoing partnership with the National Comprehensive Cancer Network and the launch of this incredibly valuable and timely program," said John Whyte, MD, Vice President, Continuing Medical Education and Chief Medical Expert, Discovery Health. "This collaboration directly aligns with Discovery Health's mission to deliver credible, high-quality Continuing Medical Education content to physicians and health care providers."
NCCN is known for developing the NCCN Clinical Practice Guidelines in Oncology(TM), a leading clinical reference for health care providers around the globe. This program will include members of the NCCN Guidelines Panel for Breast Cancer as they explore individualizing treatment for patients with metastatic breast cancer and focus on evolving data for the disease and the application in the current NCCN Guidelines.
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery